Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia

Clinical trial NCT02972983 · COMPLETED

Trial details

NCT number: NCT02972983
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Methicillin Susceptible Staphylococcus Aureus Septicemia Bacteremia

Start date: 2016-12-01
Primary completion: 2019-07-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.